Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 2Completed 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Leukemia 27Lymphoma 25Lymphoma, Non-Hodgkin 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Myelodysplastic Syndromes 21Multiple Myeloma 21Leukemia, Myeloid, Acute 21Hodgkin Disease 16Leukemia, Lymphocytic, Chronic, B-Cell 15Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12Hematologic Neoplasms 10Neuroblastoma 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Follicular 6Graft vs Host Disease 6Neoplasms, Plasma Cell 5Leukemia, Myelomonocytic, Juvenile 5Breast Neoplasms 5Hemoglobinuria, Paroxysmal 4Rhabdoid Tumor 3Neoplasms 3Lymphoma, Mantle-Cell 3Lymphoma, B-Cell 3Leukemia, Myeloid, Accelerated Phase 3Blast Crisis 3Anemia, Refractory, with Excess of Blasts 3Anemia, Aplastic 3Wilms Tumor 2Recurrence 2Primary Myelofibrosis 2

Interventions

Cyclophosphamide 67Dexamethasone 52Peripheral Blood Stem Cell Transplantation 37Lenalidomide 37Rituximab 35fludarabine phosphate 34Bortezomib 30Filgrastim 27Etoposide 27Cytarabine 25Carboplatin 25Busulfan 23Radiotherapy 22Melphalan 22Gemcitabine 22Cyclosporine 21pomalidomide 20fludarabine 20Whole-Body Irradiation 20Mycophenolic Acid 20Paclitaxel 19Methotrexate 18venetoclax 17Cisplatin 17pembrolizumab 16Calcium Dobesilate 16Bevacizumab 16Tacrolimus 14Antilymphocyte Serum 14Nivolumab 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Recurrence × Stem Cell Transplantation × Clear all
NCT01041508 2024-02-01

Clofarabine and Low Dose Total Body Irradiation as a Preparative Regimen for Stem Cell Transplant in Leukemia.

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1 Completed
18 enrolled 15 charts
LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01200329 2019-12-16

High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's Disease

M.D. Anderson Cancer Center

Phase 2 Completed
81 enrolled 8 charts
Lymphoid

Hodgkin Disease, Lymphoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡